Latest enrollment pace is ~12 per week. Being at around 165, we should be at 195 in three weeks, mid-August.

Add 28 days plus time for the analysis, we are at end of September/early October, as you predicted.

Yes, 1 patient average per trial site per week average with case numbers spiking is disappointing...

The best case would be a halt for efficacy next week with around n=120, but the bar is high...